Vaccinex 13G Filing Shows Orin Hirschman Holds 9.9% Passive Stake In Co As Of September 28
Portfolio Pulse from Benzinga Newsdesk
Orin Hirschman has acquired a 9.9% passive stake in Vaccinex (VCNX) as of September 28, according to a 13G filing with the SEC.
October 11, 2023 | 4:36 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Orin Hirschman's acquisition of a 9.9% passive stake in Vaccinex could potentially influence the company's stock price.
Orin Hirschman's acquisition of a 9.9% stake in Vaccinex is a significant investment. This could potentially influence other investors' perceptions of the company and its stock price. However, as this is a passive stake, Hirschman will not have direct control over the company's operations, which may limit the impact on the stock price.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 100